SynthesisMedicine2016

A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer.

Alessandro Sciarra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.